To keep the catch - that is the question: a personal account of the 3rd Annual EULAR Congress, Stockholm.
(2002) In Arthritis Research 4(5). p.007-007- Abstract
- The 3rd Annual EULAR Congress, held in Stockholm on 12-15 June 2002, had a turnout of 8300 delegates, almost identical to last year's record attendance level in Prague. The venue was close to ideal, allowing ample space for poster sessions in the exhibition hall. The manned poster sessions were well attended, even on the last day of the Congress. The numerous invited speakers represented the world's elite, allowing the staging of excellent state-of-the-art podium sessions. The aim of attracting the young scientific community was partly achieved, but individual delegates' dependence on industry sponsorship poses potential problems. The organization was a big improvement compared to that of the two previous congresses. Approximately 1800... (More)
- The 3rd Annual EULAR Congress, held in Stockholm on 12-15 June 2002, had a turnout of 8300 delegates, almost identical to last year's record attendance level in Prague. The venue was close to ideal, allowing ample space for poster sessions in the exhibition hall. The manned poster sessions were well attended, even on the last day of the Congress. The numerous invited speakers represented the world's elite, allowing the staging of excellent state-of-the-art podium sessions. The aim of attracting the young scientific community was partly achieved, but individual delegates' dependence on industry sponsorship poses potential problems. The organization was a big improvement compared to that of the two previous congresses. Approximately 1800 abstracts were submitted, an increase of 50%, resulting in a higher quality of accepted abstracts. The satellite symposia held every morning and late afternoon were well attended; thus, industry exposure of new products, both in podium sessions and at the exhibitions, was well accommodated. The Annual EULAR Congress consolidates its position as one of the two most important annual congresses of rheumatology, but EULAR economy and commercial aspects are still too dominant in relation to science. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/110332
- author
- Wollheim, Frank LU
- organization
- publishing date
- 2002
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Arthritis Research
- volume
- 4
- issue
- 5
- pages
- 007 - 007
- publisher
- BioMed Central (BMC)
- external identifiers
-
- scopus:84925548675
- ISSN
- 1465-9905
- language
- English
- LU publication?
- yes
- id
- 9c9a7246-9059-426d-b5f2-6328930b7d64 (old id 110332)
- alternative location
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12223107&dopt=Abstract
- date added to LUP
- 2016-04-01 16:47:33
- date last changed
- 2022-02-13 00:39:01
@article{9c9a7246-9059-426d-b5f2-6328930b7d64,
abstract = {{The 3rd Annual EULAR Congress, held in Stockholm on 12-15 June 2002, had a turnout of 8300 delegates, almost identical to last year's record attendance level in Prague. The venue was close to ideal, allowing ample space for poster sessions in the exhibition hall. The manned poster sessions were well attended, even on the last day of the Congress. The numerous invited speakers represented the world's elite, allowing the staging of excellent state-of-the-art podium sessions. The aim of attracting the young scientific community was partly achieved, but individual delegates' dependence on industry sponsorship poses potential problems. The organization was a big improvement compared to that of the two previous congresses. Approximately 1800 abstracts were submitted, an increase of 50%, resulting in a higher quality of accepted abstracts. The satellite symposia held every morning and late afternoon were well attended; thus, industry exposure of new products, both in podium sessions and at the exhibitions, was well accommodated. The Annual EULAR Congress consolidates its position as one of the two most important annual congresses of rheumatology, but EULAR economy and commercial aspects are still too dominant in relation to science.}},
author = {{Wollheim, Frank}},
issn = {{1465-9905}},
language = {{eng}},
number = {{5}},
pages = {{007--007}},
publisher = {{BioMed Central (BMC)}},
series = {{Arthritis Research}},
title = {{To keep the catch - that is the question: a personal account of the 3rd Annual EULAR Congress, Stockholm.}},
url = {{https://lup.lub.lu.se/search/files/4782135/623653.pdf}},
volume = {{4}},
year = {{2002}},
}